Name: Medigen Selected for WHO Trial
Uploaded: 2021-10-27T18:28:23Z
Description: Taiwan’s homegrown COVID vaccine, Medigen, is set to enter clinical trials under a WHO platform. The government hopes this could pave the way for greater international approval of the vaccine.

Medigen Selected for WHO Trial

Reporter/Provider - Sandy Chi, Asnaya Chou

class="meta mb-0">Publish Date - 2021-10-27T18:28:23Z0 views

Taiwan’s homegrown COVID vaccine, Medigen, is set to enter clinical trials under a WHO platform. The government hopes this could pave the way for greater international approval of the vaccine.